Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
KMDA
IL0010941198
Pharmaceuticals
| Market Cap | 1.23B 403M 353M 326M 300M 567M 38.86B 576M 3.9B 1.53B 19.01B 1.51B 1.48B 65.51B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.23B 403M 353M 326M 300M 567M 38.86B 576M 3.9B 1.53B 19.01B 1.51B 1.48B 65.51B | EV / Sales 2026 * |
2.05x | EV / Sales 2027 * | 1.88x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.07% | +4.32% | - | - | 405M | |
| +0.06% | +2.39% | +24.45% | -6.10% | 68.85B | |
| -0.54% | +1.02% | +37.33% | +189.96% | 52.13B | |
| -3.65% | +34.50% | +34.50% | +34.50% | 43.46B | |
| -0.58% | -0.23% | -52.36% | -53.82% | 41.24B | |
| -1.57% | -2.94% | +65.37% | -26.15% | 30.41B | |
| -0.66% | -8.47% | +98.05% | -50.84% | 24.53B | |
| -1.83% | +1.14% | +71.46% | +80.49% | 23.42B | |
| +3.99% | +3.12% | +3.87% | +200.81% | 19.75B | |
| +0.26% | +0.39% | +72.12% | +126.52% | 16.57B | |
| Average | -0.10% | -1.02% | +39.42% | +55.04% | 35.6B | |
| Weighted average by Cap. | -0.69% | -0.46% | +32.18% | +45.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 600M 197M 172M 159M 147M 277M 18.97B 281M 1.91B 747M 9.28B 739M 722M 31.97B | 655M 214M 188M 174M 160M 302M 20.68B 306M 2.08B 814M 10.12B 805M 788M 34.86B |
| Net income | 73.89M 24.21M 21.22M 19.62M 18.04M 34.04M 2.33B 34.59M 235M 91.95M 1.14B 90.91M 88.93M 3.94B | 105M 34.54M 30.28M 27.99M 25.74M 48.57M 3.33B 49.35M 335M 131M 1.63B 130M 127M 5.62B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
